TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
SBM Life Science AB
Closing information (x1000 NOK)
| Closing information | 2024/09 | 2023/09 | 2022/09 |
| Turnover |
206,445
|
176,393
|
205,433 |
| Financial expenses |
3,366
|
5,947
|
5,088 |
| Earnings before taxes |
775
|
-1,333
|
4,040 |
| EBITDA |
4,134
|
3,761
|
8,615 |
| Total assets |
127,722
|
102,720
|
159,884 |
| Current assets |
126,887
|
101,665
|
158,956 |
| Current liabilities |
109,815
|
86,423
|
142,742 |
| Equity capital |
17,906
|
16,298
|
17,142 |
| - share capital |
52
|
49
|
48 |
| Employees (average) |
15
|
18
|
19 |
Financial ratios
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Solvency |
14.0%
|
15.9%
|
10.7% |
| Turnover per employee |
13,763
|
9,800
|
10,812 |
| Profit as a percentage of turnover |
0.4%
|
-0.8%
|
2.0% |
| Return on assets (ROA) |
3.2%
|
4.5%
|
5.7% |
| Current ratio |
115.5%
|
117.6%
|
111.4% |
| Return on equity (ROE) |
4.3%
|
-8.2%
|
23.6% |
| Change turnover |
19,109
|
-33,648
|
10,820 |
| Change turnover % |
10%
|
-16%
|
6% |
| Chg. No. of employees |
-3
|
-1
|
-8 |
| Chg. No. of employees % |
-17%
|
-5%
|
-30% |
Total value of public sale
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.